The Long Run with Luke Timmerman

Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

Mar 1, 2021
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Biote
03:02 • 2min
3
Do You Have a Million Dollars to Have Impact?
05:31 • 2min
4
Do You Think You Can Incubate Innovation Within Companies?
07:49 • 3min
5
How to Scale a Company Without Building a Whole Lot of Human Capital
10:25 • 2min
6
Is This a Place Where Company Builders Are Made?
12:16 • 3min
7
I Think the Next Pandemics Will Be Prepared.
14:55 • 2min
8
Neuro Degeneration and Mental Health
17:16 • 3min
9
Cynthago - What Kind of Investment Opportunities Do You See in Your New Fund?
20:16 • 3min
10
The Pandemic and Resilients
22:48 • 2min
11
The Best Semi Conductors in the World, Right?
25:15 • 3min
12
How Can You Rethink the Supply Chain of Your Body?
27:49 • 2min
13
Is There Room for Innovation in the Investment Landscape?
30:15 • 3min
14
Is There an Opportunity to Invest in Basic Research?
33:40 • 2min
15
Celangine Therapy Reviews - Is There a Big Bottleneck?
35:54 • 2min
16
Biotac
37:46 • 2min
17
The Biggest Round Ever, Isn't It?
39:33 • 3min
18
What's the One Good Book You've Read Since the Pandemic?
42:20 • 3min
19
The Secret to America's Success Is the Combination of Innovation and Idiocy
45:15 • 3min
20
The Long Run - A Production of Timberman Report
47:55 • 1min